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Abstract
Background
Antimicrobial stewardship (AMS) programs promote appropriate use of antimicrobials and
reduce antimicrobial resistance. Technological developments have resulted in smartphone
applications (apps) facilitating AMS. Yet, their impact is unclear.
Objectives
Systematically review AMS apps and their impact on prescribing by physicians treating in-
hospital patients.
Data sources
EMBASE, MEDLINE (Ovid), Cochrane Central, Web of Science and Google Scholar.
Study eligibility criteria
Studies focusing on smartphone or tablet apps and antimicrobial therapy published from
January 2008 until February 28th 2019 were included.
Participants
Physicians treating in-hospital patients.
Interventions
AMS apps
Methods
Systematic review.
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Results
Thirteen studies met the eligibility criteria. None was a randomized controlled trial. Methodo-
logical study quality was considered low to moderate in all but three qualitative studies. The
primary outcomes were process indicators, adherence to guidelines and user experience.
Guidelines were more frequently accessed by app (53.0% - 89.6%) than by desktop in three
studies. Adherence to guidelines increased (6.5% - 74.0%) significantly for several indi-
cations after app implementation in four studies. Most users considered app use easy
(77.4%—>90.0%) and useful (71.0%—>90%) in three studies and preferred it over guide-
line access by web viewer or booklet in two studies. However, some physicians regarded
app use adjacent to colleagues or patients unprofessional in three qualitative studies. Sus-
ceptibility to several antimicrobials changed significantly post-intervention (from 5%
decrease to 10% - 14% increase) in one study.
Conclusions
Use of AMS apps seems to promote access to and knowledge of antimicrobial prescribing
policy, and increase adherence to guidelines in hospitals. However, this has been assessed
in a limited number of studies and for specific indications. Good quality studies are neces-
sary to properly assess the impact of AMS apps on antimicrobial prescribing. To improve
adherence to antimicrobial guidelines, use of AMS apps could be considered.
Introduction
Appropriate prescribing of antimicrobials is crucial for individual patients to increase the
chance of therapeutic success and to prevent spread of antimicrobial resistance (AMR) on a
broader scale. For this reason, governments and healthcare institutions have developed and
implemented antimicrobial stewardship (AMS) programs to improve appropriate prescribing
[1–3].
Local antimicrobial guidelines help physicians to prescribe appropriate antimicrobial ther-
apy. However, guidelines change and increasing complexity of care requires easily accessible
and frequently updated guidelines. Printed booklets and digital documents may not be suffi-
cient for this purpose. In the age of information technology (IT), many processes within the
healthcare system have been digitized or automated and IT has become an intrinsic part of
modern medicine [4–6]. IT interventions such as electronic health records (EHR), clinical
decision support systems (CDSS), and antimicrobial drug approval systems increase guideline
adherent prescribing. Such tools assist in a more timely intravenous to oral switch, and
decrease overall antimicrobial consumption [4, 7, 8]. Nevertheless, appropriate prescribing of
antimicrobials can still be improved [9, 10]. AMS is important for general practice and hospi-
tals, but prevalence of antimicrobial resistant microorganisms is the highest in hospitals, even
in countries with overall low resistance rates [11, 12]. Furthermore, reserve antimicrobials are
mainly used in hospitals [11, 12].
With the introduction of smartphones, applications (apps) can be accessed without the
necessity of a non-mobile desktop and can simultaneously provide a framework to integrate
CDSSs. Besides accessibility, apps offer several other advantages such as the most up to date
content, short start-up time and administrator privileges to inform users of specific updates
[13].
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In Europe and North America the number of unique mobile phone subscribers was respec-
tively 85% and 84% at the end of 2017. In the same year over 318.000 mobile health (mHealth)
apps were available in app stores [14, 15]. The majority of healthcare workers utilizes mHealth
apps (77.2%) on a regular basis in the United States [16]. Although smartphone apps have high
potential for becoming a key component of AMS programs, user experience, uptake and effect
on prescription of antimicrobials have not been systematically reviewed to the best of our
knowledge. The aim of this study was to systematically review antimicrobial stewardship apps
and their impact on prescribing by physicians treating in-hospital patients
Methods
This systematic review was performed in accordance with the guidelines of Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement [17]. (S1 Text).
Eligibility criteria
Studies which focused on AMS app use by physicians treating in-hospital patients were assessed
for eligibility. Studies focusing on smartphone or tablet apps and antimicrobial therapy published
from January 2008 until February 28th 2019 were included. The year 2008 was chosen since the
two most popular app stores, App Store (iOS) and the precursor of Google Play (Android) were
launched that year [18, 19]. We included randomized controlled trials (RCT), non-RCTs, time
series, before-after studies and qualitative studies. Excluded were studies solely considering anti-
microbial prophylaxis, only including patients younger than 18 years of age, case reports, confer-
ence papers, editorials, letters to editor and reviews or meta-analysis. Language was no exclusion
criterion. We excluded studies which only described app use in the general practice and outpatient
setting. In these settings, prevalence and severity of infectious diseases, available antimicrobials
and routes of administration differ significantly compared to an in-hospital setting.
Search strategy and review design
EMBASE, MEDLINE (Ovid), Cochrane Central, Web of Science and Google Scholar databases
were searched for relevant quantitative and qualitative studies published before February 28th
2019. The search strategy was developed together with an information specialist and specified
for each database. Search terms included “antimicrobial”, “anti-infective agent”, “prescrip-
tion”, “application” and “mobile phone” (S2 Text). Search results were imported to Endnote
(Clarivate Analytics, Philadelphia, PA, USA). After removal of duplicate studies, two investiga-
tors (RH and DF) independently screened all articles on title and abstract. Articles were
included for full text review if selected by either investigator. In case of doubt, articles were
included for full text review. Both investigators independently assessed full texts for eligibility
and extracted data. Disagreements were resolved in discussion with a third investigator (AV).
Study outcome
Primary study outcomes are process indicators such as number of downloads, average
monthly use and guidelines assessed, adherence to guidelines and user experience. Secondary
study outcomes are drug consumption, susceptibility and costs.
Data analysis
Data was extracted using standardized forms (S3 Text). The quality of included studies was
independently assessed by two investigators (RH and DF). Disagreements were resolved by
discussion with a third investigator (AV). To assess the five different study designs we used
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five risk of bias assessment tools [20–24]. Due to large variations in study design and outcome
parameters, study outcome could not be pooled and used for meta-analysis.
Results
Study characteristics
Thirteen studies met the eligibility criteria and were evaluated in this systematic review (Fig 1).
Primary outcomes were process indicators such as downloads, average app use and time spent
per guideline, evaluated in seven studies. Changes in adherence to guidelines and user experi-
ence were analysed in four and five studies, respectively. Antimicrobial consumption was
Fig 1. Study selection.
https://doi.org/10.1371/journal.pone.0239751.g001
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evaluated in two studies (Table 1). In ten of the thirteen studies the app was custom built for
the study (Table 2).
Study quality
Emphasis on app dissemination and use, impact of app use and user experience resulted in
quantitative, qualitative and mixed methods study designs such as: uncontrolled before-after
(five), controlled before-after (two), interrupted time series (one), cross-sectional (six) and
qualitative studies (three). Quality was evaluated with the corresponding tools [20–24]. Study
designs varied greatly due to different metrics studied, e.g. app dissemination and use, impact
of app use and user experience. Overall, methodological study quality was considered low to
moderate for the before-after, interrupted time series and cross-sectional studies [25–35] and
moderate to high for qualitative studies [30, 35, 36] (S4 Text). In most studies participants and
outcome assessors were not blinded. Furthermore, outcomes were usually measured at one
time point. Finally, the amount of eligible physicians enrolled was generally unclear as well as
the loss to follow-up because information on user retention was lacking.
Process indicators
Seven observational studies [26, 28, 30, 32–35] reported analytics of app use (Table 3). Five
studies [26, 30, 32–34] evaluated total number of downloads. All registered an increase of
downloads during their study periods (3–14 months). A study that assessed an app containing
Table 1. Study characteristics.
Author Country Study
period
Study design Setting Primary outcome Patients included
Pre-
intervention
Intervention
Charani (2013) UK 2011–
2012
Cross-sectional, before-after
& qualitative
Hospital Process indicators, user experience n/a n/a
Payne (2014) UK N/A Before-after & qualitative Hospital Process indicators, user experience n/a n/a
Panesar (2016) Canada 2013 Cross-sectional & before-
after
Hospital Process indicators, user experience n/a n/a
Blumenthal
(2017)
USA 2014–
2016
Cross-sectional Ward Antimicrobial consumption 148 199
Charani (2017) UK 2008–
2014
Interrupted time series Hospital Adherence to guidelines N/A N/A
Fralick (2017) Canada 2015 Before-after Ward Knowledge of prescribing, user experience n/a n/a
Haque (2017) Bangladesh 2015 Before-after Ward Adherence to guidelines 325 516
Hoff (2018) USA 2016–
2017
Cross-sectional Hospital Process indicators n/a n/a
Tuon (2017) Brazil 2014–
2015
Before-after Hospital Antimicrobial consumption, susceptibility and
cost, process indicators
n/a n/a
Shenouda
(2018)
UK N/A Qualitative Hospital User experience n/a n/a
Young (2018) USA 2016–
2017
Cross-sectional Hospital Process indicators n/a n/a
Antonello
(2019)
Brazil 2010–
2015
Cross-sectional Hospital Adherence to guidelines 99 107
Yoon (2019) New
Zealand
2016 Before-after Hospital Process indicators, adherence to guidelines 1041 1064
N/A: not available; n/a: not applicable.
https://doi.org/10.1371/journal.pone.0239751.t001
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all hospital antimicrobial guidelines recorded an increase in average monthly app accessions
during a 29-month period [32]. In contrast, the monthly app accessions decreased over 3
months in the study of Yoon et al. [34] which assessed an app containing only two guidelines,
the treatment of community-acquired pneumonia and urinary tract infection. Additionally,
clinicians accessed the guidelines more frequently by app than by desktop in all three studies
evaluating number of accessions [26, 28, 30]. One study reported a decrease in time spent per
individual guideline over the course of the study possibly demonstrating familiarization with
the app [32]. The most frequently accessed guidelines were those outlining treatment for respi-
ratory, skin & soft tissue and genitourinary infections [26, 28, 32, 34].
Adherence to guidelines
Four studies analysed whether empirical prescribing of antimicrobials was according to guide-
lines, such as choice of drug, dose, interval and route of administration [25, 31, 34, 37].
(Table 4) The study of Charani et al. in which all antimicrobial guidelines were implemented
in the app reported a significant increase in adherence to guidelines in surgical wards and a
non-significant increase in general medicine wards [37]. This increase persisted after six and
Table 2. App characteristics.
Author App name Custom
built
Operating
System
Content of app Clinical indiction Standalone Interactive /
static
Charani
(2013)
IAPP Yes iOS &
Android
Local therapeutic antimicrobial guidelines,
calculator
Any infectious disease
listed in guidelines
Yes Interactive
Payne (2014) iTreat Yes iOS Local therapeutic antimicrobial guidelines &
antimicrobial list
Any infectious disease
listed in guidelines
Yes Static
Panesar
(2016)
MicroGuide No iOS, Android
& WP
Local therapeutic antimicrobial guidelines & AMS
section
Any infectious disease
listed in guidelines
Yes Static
Blumenthal
(2017)
N/A Yes WEB-based Local antimicrobial allergy guidelines beta-lactam antibiotics for
patients with listed
penicillin allergy
Yes Interactive
Charani
(2017)
IAPP Yes iOS &
Android
Local therapeutic antimicrobial guidelines,
calculator
Any infectious disease
listed in guidelines
Yes Interactive
Fralick
(2017)
N/A Yes iOS &
Android
Local therapeutic antimicrobial guidelines &
susceptibility results
Any infectious disease
listed in guidelines
Yes Static
Haque (2017) Rehydration
Calculator
Yes Android Therapeutic WHO guideline, calculator Diarrhea Yes Interactive
Hoff (2018) MicroGuide No iOS, Android
& WP
Local therapeutic antimicrobial guidelines,
antimicrobial list, susceptibility results & renal
dosing guidelines
Any infectious disease
listed in guidelines
Yes Static
Tuon (2017) N/A Yes iOS &
Android
Local therapeutic antimicrobial guidelines &
susceptibility results
Any infectious disease
listed in guidelines
No Static
Shenouda
(2018)
MicroGuide No iOS, Android
& WP
Local therapeutic antimicrobial guidelines Any infectious disease
listed in guidelines
Yes Static
Young (2018) N/A Yes iOS &
Android
Local therapeutic antimicrobial guidelines,
antimicrobial list, susceptibility results,
perioperative antibiotic prophylaxis & dose
adjustment based on renal funcion guideline
>50 infectious diseases
listed in guidelines
No Interactive
Antonello
(2019)
ATB Fêmina Yes iOS &
Android
Local diagnostic & therapeutic antimicrobial
guidelines
Pyelonephritis during
pregnancy
Yes Static
Yoon (2019) SCRIPT Yes iOS &
Android
Local therapeutic antimicrobial guidelines CAP and UTI Yes Interactive
Custom built: built for the study; Standalone: not integrated into the EHR system; Interactive: includes interactive elements, such as decision trees or calculators; N/A:
not available; WP: Windows phone.
https://doi.org/10.1371/journal.pone.0239751.t002
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Table 3. Process indicators.
Author Downloads Average monthly use Individual sessions Time used per feature/session Accessed guidelines
Initial Total Initial Follow-up App Non-app Initial Follow-up (most frequent to least
frequent)
Charani
(2013)
376
times
in first
month
990
times
after 12
months
250–300
average
monthly users
N/A 1900 monthly
average
individual
sessions
(89.6%)
221 average
monthly
individual
sessions on the
intranet
version
(10.4%)
N/A N/A N/A
Payne
(2014)
N/A N/A N/A N/A N/A N/A Time spent per day on
the antimicrobial
formulary (users): 0
minutes (8), 1 to 10
minutes (16), 11 to 20
minutes (5) and 21 to 30
minutes (2). Time spent
per day on management
protocols (users): 0
minutes (9), 1 to 10
minutes (20), 11 to 20
minutes (2) and 21 to 30
minutes (0)
N/A N/A
Hoff
(2017)
N/A 3056
times
over 14
months
N/A N/A 9259 times in
total (53.0%)
8214 times in
total per web
viewer (47.0%)
N/A N/A Community-acquired
pneumonia (3725),
Antibiogram—Gram-
negatives (3216),
Antibiogram Gram-
positives (2931),
Antimicrobial dosing in
renal insufficiency (2918),
Spontaneous bacterial
peritonitis (2576),
Uncomplicated cystitis
(2139)
Tuon
(2017)
N/A 1741 N/A N/A N/A N/A 50% of all sessions < 1
min.
N/A N/A
Panesar
(2016)
N/A 2013
times
over 10
months
1182 average
monthly
accessions in
first year
(range: 1005–
1615)
1483 average
monthly
accessions in
19 months
(range: 945–
2140)
>16 000
times in total
N/A 12.5 seconds average per
individual guideline in
first year
10.6
seconds
average per
guideline 19
months
UTI (lower), Pneumonia,
Cellulitis, UTI (upper/
pyelonephritis), Sepsis
Young
(2018)
N/A N/A 1257–1953
sessions/
month
N/A 18860
sessions on
1887 unique
devices (per
year) (79.8%)
4761 sessions
(desktop) on
3151 desktops
(per year)
(20.2%)
Mean session duration:
2:22 min
N/A UTI 336–688 sessions/
month, RTI 329–596
sessions/month, SSTI 289–
615 session/month, GI
108–195 sessions/month,
genital infections 52–153
sessions/month
Yoon
(2019)
53
times
in first
month
145
times
after 3
months
21 average
accessions per
user in first
month
12 and 11
average
accessions per
user in second
resp. third
month
N/A N/A CAP guideline: median
of 11 seconds (IQR
7–17). UTI guideline:
median of 18 seconds
(IQR 12–29)
N/A Respiratory (847), Skin
and soft tissue (663),
Gastrointestinal tract
(500), Sepsis (467),
Genitourinary (350), ENT
(335), CNS (278)
The process parameters reported in evaluated studies. CAP: community-acquired pneumonia; CNS: central nervous system; ENT: ear, nose & throat; GI:
gastrointestinal infection; IQR: inter quartile range; N/A: not available; RTI: respiratory tract infection; SSTI: skin and soft tissue infection; UTI: urinary tract infection.
https://doi.org/10.1371/journal.pone.0239751.t003
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twelve months. Two studies [25, 31] reported an significant increase in adherence to guidelines
for pyelonephritis and uncomplicated diarrheal diseases respectively during the intervention
period. One study [34] showed increased adherence to the community-acquired pneumonia
guideline in one hospital, but not in the other. Also, no change in adherence to the UTI guide-
line was shown in any of the three participating hospitals. Documentation of stop/review dates
and indication for starting antimicrobials in the medical charts was evaluated in one study
[37]. No change in documentation of stop/review dates was reported during or after the inter-
vention period. Remarkably, documentation on the reason to start antimicrobials decreased
significantly during intervention and this sustained during follow up measurements over the
next two years [37].
Table 4. Adherence to guidelines.
Author Country Study duration Number of patients
included
Outcome Collection of
outcomes
Antimicrobial
guideline(s)
Change in guideline
adherent prescribing
Pre-
intervention
Intervention Pre-
intervention
Intervention Baseline to
intervention
Follow-
up
Charani
(2017)
UK 36 months 36 months N/A N/A Choice of
antimicrobial
Biannual PPS All available
hospital
guidelines
Medicine: 6.48%
increase, 95% CI
= –1.25 to 14.20
Surgery: 6.63%
increase, 95%
CI = 0.15–13.10,
p<0.05
Effect
positive
after 6
and 12
months
Haque
(2017)
Bangladesh 1.5 months 1.5 months 325 516 Choice of
antimicrobial
Continuous
measurement
Diarrhea District hospital:
13% to 87%,
p < 0.001 Sub-
district hospital:
63% to 99%,
p = 0.35
N/A
Antonello
(2019)
Brazil 7 months 11 months 99 107 Choice of
antimicrobial,
dosage,
Interval, route
of
administration
Continuous
measurement
Pyelonephritis
during
pregnancy
Appropriate
choice of
antimicrobial
drug 83.8% to
100%, p < 0.001;
Appropriate
dosage 100% to
100%, p = 1;
Appropriate route
of administration
97.0% to 100%,
p = 0.018;
Appropriate
interval 91.9% to
100%, p = 0.004
N/A
Yoon
(2019)
New
Zealand
5 months 3 months 1041 1064 Guideline
adherherence
based on:
Choice of
antimicrobial,
dosage, route of
administration
Continuous
measurement
CAP and UTI CAP: Hospital 1:
19% to 27%,
p = 0.04; Hospital
2: 9% to 9%,
p = 0.98 UTI:
Hospital 1: 47%
to 50%, p = 0.49;
Hospital 2: 45%
to 40%, p = 0.28;
Hospital 3: 24%
to 29%, p = 0.25
N/A
Adherence to guidelines parameters reported in evaluated studies. CAP: community-acquired pneumonia; N/A: not available; PPS: point prevalence study; UTI: urinary
tract infection
https://doi.org/10.1371/journal.pone.0239751.t004
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User experience
In five studies user experience was analysed by means of interviews, focus groups or surveys
[27, 30, 32, 35, 36]. The app was considered easy to use by 77.4% [35], 88.9% [27] and>90.0%
[32] and useful by 71.0% [35], 85.2% [27] and>90.0% [32] of the users in before-after surveys
with 31, 27 and 112 respondents, respectively. In one survey, 59 respondents reported app use
increased their knowledge base regarding antimicrobial prescribing, while 81% reported app
use helped them adhere to the guidelines [30]. Another survey reported 68% of the 31 respon-
dents found app use time saving [35] Interviewees [36] as well as>90% of 112 survey respon-
dents [32] favoured the app guidelines over the web viewer or paper guidelines. Discomfort
using the app in front of patients or colleagues due to a sense of unprofessionalism was men-
tioned by 20.0% of 59 survey respondents [30] and 35.7% of 14 interviewees [36] but this was
not experienced by others [32].
Frequent app use was inversely associated (survey respondents (SR) 106; risk ratio (RR)
0.03; confidence interval (CI) 0.0018–0.5; p = 0.0002) with preferring senior physician advice
over antimicrobial guidelines, while frequent app use encouraged users to discuss incorrect
prescribing by colleagues (SR 92; RR 3.8; CI 1.5–9.7; p = 0.005) [32]. Furthermore, app use was
associated with a 1.1 point (p = 0.04) higher change in knowledge score of antimicrobial pre-
scribing in 62 medical students and junior physicians compared to the control group [27] and
improved awareness of antimicrobial stewardship (SR 91; RR 6.8; CI 2.1–21.7; p = 0.001) [32].
Drug consumption, susceptibility and costs
Monthly average antimicrobial drug consumption was the focus of one study conducted in
Brazil [33]. The app used in this study contained guidelines advising against use of some anti-
microbials (e.g. carbapenems) while encouraging use of others (i.e. aminoglycosides) based on
cost and susceptibility profile. After app introduction, the use of aminoglycosides and cefe-
pime increased significantly while the use of piperacillin/tazobactam and meropenem
decreased significantly. However, it should be noted that during the study period piperacillin/
tazobactam was replaced by cefepime within the guideline for hospital-acquired infections.
Furthermore, a significant increase in susceptibility to meropenem (73%–83%, p< 0.05) and
polymyxin (69%–83%, p< 0.05) and a significant decrease in susceptibility to cefepime was
described post-intervention (62%–57%, p< 0.05) [33]. In the year of implementation, a signif-
icant reduction of $296,485 USD (p<0.05) in antimicrobial drug costs was attained compared
to the pre-implementation year. In a different study the optimal approach to promote safe use
of beta-lactam antibiotics in inpatients with a history of penicillin allergy was evaluated [29].
Penicillin and cephalosporin use increased in the intervention period after introduction of a
decision support app containing a decision tree for beta-lactam antibiotics (50% of 199
patients) compared to the standard of care period (38% of 148 patients). In the app interven-
tion period odds of treatment with penicillin and cephalosporin were significantly increased
(aOR 1.8% [95% CI 1.1, 2.9]).
Discussion
In this systematic review, 13 studies which assessed antimicrobial stewardship smartphone
apps in the hospital setting were analysed. Several studies measured different outcomes,
applied different designs and varied in quality. In the reviewed studies, AMS apps were
increasingly used or downloaded after implementation in five studies, guideline adherent pre-
scribing of antimicrobials increased overall significantly in four studies and in one study this
resulted in significantly less resistance to some antimicrobials and to a significant decrease in
total drug costs. In general, users favoured the app based guidelines over web or paper versions
PLOS ONE Use of stewardship smartphone applications by physicians and prescribing of antimicrobials in hospitals
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in two studies, but some reported that app use in front of patients or colleagues felt unprofes-
sional in three studies. Overall, although of varying quality, the studies indicate that AMS apps
might increase guideline accessibility and offer physicians a friendly and efficient way of using
antimicrobial guidelines.
Content of all but one app in the reviewed studies focused solely on therapy to improve the
prescribing of antimicrobials according to the guidelines. To evaluate appropriate prescribing
of antimicrobials, different outcome parameters were selected: choice of antimicrobials, dose,
dosing interval and route of administration. One study also included indication and stop/
review date documentation [37]. This variation in outcome parameters reflects the difficulty in
defining appropriate antimicrobial prescribing. Since Gyssens et al. first described quality indi-
cators (QI) for appropriate antimicrobial prescribing in 1992, QI’s have been added and
debated in the infectious diseases community without reaching consensus, although many dif-
ferent quality indicators have been proposed [38–40]. In the studies reviewed, a limited set of
outcome parameters was evaluated, leaving out many insightful quality indicators of appropri-
ate antimicrobial prescribing, such as switch from intravenous to oral therapy and timely initi-
ation of antimicrobial therapy [39]. Clearly defining quality indicators is essential in order to
prevent interpretive bias and to compare studies promoting prescribing interventions.
A factor that was not always taken into account but should be considered for each AMS app
is how users experience them. Several studies show that physicians with different backgrounds
are enthusiastic about apps, find them user-friendly and helpful in their work and would rec-
ommend them to colleagues [41, 42]. In the studies reviewed, some physicians regarded smart-
phone use unprofessional in front of patients. However, a study focussing on outpatients
found that more than half of patients were “fine” when physicians used their smartphone to
access information during consultations, and thirteen percent reported it was “not fine” [43].
Initially used for calling and messaging, the increasing number of features and applications
helped evolve the mobile phone into a possible valuable multifunctional tool for personal and
professional use.
AMS apps could help to educate students, but also junior and senior physicians, in antimi-
crobial use. Although for students the education on antimicrobials and AMS varies within and
between countries, globally, the knowledge of appropriate antimicrobial prescribing of final-
year medical students is limited [44–47]. Additionally, prescribing errors are prevalent among
junior physicians who are usually responsible for the majority of drug prescriptions in hospi-
tals [48, 49]. The reviewed studies showed that AMS apps have additional educational value
by improving knowledge of medical students and junior physicians on the prescribing of anti-
microbials. Furthermore, as some of the younger smartphone using doctors have become
attending physicians, smartphones will be an increasingly used tool for the prescription of
antimicrobials.
The effect of clinical decision support systems (CDSS) on antimicrobial prescribing in the
healthcare setting such as hospitals have been evaluated in many studies including several ran-
domized controlled trials and systematic reviews [50–52]. Many are designed to improve
guideline adherent prescribing of antimicrobials and are integrated into the EHR. Alterna-
tively, almost all studied apps in our systematic review are standalone facilitating easy imple-
mentation in hospitals, are low cost and pose no risk in regard to losing patient data. However,
a standalone system lacks patient specific data such as allergies, lab results, microbiological test
results and previous treatment with antimicrobials which are mandatory to assess before anti-
microbials can appropriately be prescribed [52]. Overall, CDSS have a positive effect on adher-
ence to guidelines for antimicrobial treatment and decreased antimicrobial consumption. Yet,
similar to our findings, these outcomes were not unanimous [50, 51]. Furthermore, the studies
we reviewed lacked important clinical outcomes reported in the studies evaluating CDSS such
PLOS ONE Use of stewardship smartphone applications by physicians and prescribing of antimicrobials in hospitals
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as mortality, length of stay and time to therapy. As for AMS apps user experience is an impor-
tant stepping stone for successful CDSS implementation. In spite of many studies on CDSS
and its impact on antimicrobial prescribing the need for good quality studies remains for this
IT-intervention too [50–52].
Strengths & limitations
This systematic review has some strengths and limitations. One of the strengths is the clear
start date of studies on this subject which coincides with the date app stores launched. A limi-
tation is the exclusion of studies focusing on general practice or outpatient care. Therefore, we
cannot draw conclusions on the advantage of AMS app use in these settings. Since the overall
methodological study quality varied considerably and comparison between studies was limited
due to large variations in study design and outcome parameters, only cautious conclusions
could be drawn. Currently, the impact of a smartphone app on antimicrobial prescribing by
physicians in hospitals is being evaluated in an international randomized trial [53].
Conclusions
In this systematic review, the crossroad of healthcare and smartphone technology was
explored. Smartphones may be used to improve knowledge of antimicrobial stewardship, to
access antimicrobial guidelines and thereby improve important aspects of healthcare. During
implementation of AMS apps, physician opinions and app uptake should be considered to
optimize its impact. The small number of studies on AMS apps illustrate the novelty of this
research area. Additionally, the quality of the data was limited. High quality, randomized,
multi-centre studies including robust clearly defined clinical, microbiological and process out-
comes are needed to evaluate the impact of AMS apps on antimicrobial prescribing and its
role within healthcare.
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